1000017-97-9

Basic information

• Product Name: ethyl 5-aMino-1,5-dihydroiMidazo[1,2-a]pyridin-2-carboxylate
• Synonyms: ethyl 5-aMino-1,5-dihydroiMidazo[1,2-a]pyridin-2-carboxylate;Ethyl 5-aMinoiMidazo[1,2-a]pyridine-2-carboxylate hydrate, 95%;Ethyl 5-amino-1H-imidazo[1,2-a]pyridine-2-carboxylate;5-Amino-2-(ethoxycarbonyl)imidazo[1,2-a]pyridine
• CAS NO: 1000017-97-9
• Molecular Formula: C10H13N3O2
• Molecular Weight: 207.22912
• Product Categories: Heterocycle-Pyridine series
• Mol File: 1000017-97-9.mol

Chemical Properties

• Melting Point: 216-218℃
• Appearance: /
• Density: 1.35
• Storage Temp.: 2-8°C
• PKA: 5.46±0.50(Predicted)
• CAS DataBase Reference: ethyl 5-aMino-1,5-dihydroiMidazo[1,2-a]pyridin-2-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 5-aMino-1,5-dihydroiMidazo[1,2-a]pyridin-2-carboxylate(1000017-97-9)
• EPA Substance Registry System: ethyl 5-aMino-1,5-dihydroiMidazo[1,2-a]pyridin-2-carboxylate(1000017-97-9)

Safety Data

• Hazardous Substances Data: 1000017-97-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research and Drug Development:
Ethyl 5-amino-1,5-dihydroimidazo[1,2-a]pyridin-2-carboxylate is used as a chemical intermediate for the synthesis of new drugs and pharmaceutical compounds. Its unique structure and functional groups, such as the ethyl ester and amino group, make it a promising candidate for the development of novel therapeutic agents.
Used in Medicinal Chemistry:
Ethyl 5-amino-1,5-dihydroimidazo[1,2-a]pyridin-2-carboxylate is used as a building block in the design and synthesis of new chemical entities with potential medicinal properties. Its imidazo[1,2-a]pyridine core and substituents can be modified to explore various biological activities and optimize the pharmacokinetic and pharmacodynamic profiles of the resulting compounds.
Used in Drug Discovery:
Ethyl 5-amino-1,5-dihydroimidazo[1,2-a]pyridin-2-carboxylate is used as a starting material in the drug discovery process. Its chemical properties and structural features can be exploited to identify new lead compounds with potential therapeutic applications. High-throughput screening and structure-activity relationship studies can be performed to evaluate its biological activity and optimize its potency and selectivity.
Used in the Treatment of Various Diseases and Conditions:
Although the specific pharmacological and biological properties of ethyl 5-amino-1,5-dihydroimidazo[1,2-a]pyridin-2-carboxylate have not been extensively studied, its structure suggests that it may have potential as a therapeutic agent for the treatment of various diseases and conditions. Further research and development are required to explore its potential applications in the medical field and to determine its efficacy and safety profile.

Upstream product

• 141-86-6 2.6-diaminopyridine 
• 70-23-5 ethyl Bromopyruvate 

Relevant articles and documents

INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF

The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.

HETEROARYL AMIDE DERIVATIVES

Heteroaryl amide derivatives are provided, of the Formula: wherein variables are as described herein. Such compounds are ligands that may be used to modulate specific receptor activity in vivo or in vitro, and are particularly useful in the treatment of conditions associated with pathological receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for using such compounds to treat such disorders are provided, as are methods for using such ligands for receptor localization studies.